Gastrointestinal Therapeutics Market Analysis Report By Type (Branded, Generics), By Route of Administration, By Application (Ulcerative Colitis, Crohn's Disease, GERD), By Distribution Channel, And Segment Forecasts, 2018 - 2025

Published: Mar, 2018 | Pages: 132 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global gastrointestinal therapeutics market size is expected to reach USD 65.1 billion by 2025, according to a new report by Grand View Research, Inc., registering a 6.6% CAGR during the forecast period. Growing geriatric population prone to gastrointestinal indications is one of the key factors anticipated to contribute to market growth. According to a report by WHO, colon cancer caused nearly 694,000 deaths in 2014.

Growing geriatric population, especially in emerging economies, is expected to drive market growth over the coming years. Furthermore, initiatives undertaken by the Centers for Disease Control and Prevention (CDC) to promote cancer screening nationwide is expected to boost market growth over the forecast period. The Division of Cancer Prevention and Control (DCPC) supports National Colorectal Cancer Action Campaign (NCCCP) and provides funds to aid research studies and implement strategies to control colorectal cancer. This increase in initiatives for screening is expected to fuel sales of therapeutics and present lucrative growth opportunities to the market.

Further key findings from the report suggest:

• Based on product type, the branded drugs segment dominated in 2016 owing to high potency drugs such as biologics and proton pump inhibitors. High growth of branded drugs over recent years is a result of positive patient outcomes and synergistic effect of various drugs used in conjunction in the treatment regimen

• Generics are expected to expand at a lucrative CAGR owing to their high cost-efficiency and rising number of patent expirations

• Ulcerative colitis accounted for the second-largest share in terms of application in 2016 owing to high clinical urgency to curb growing prevalence of ulcerative colitis

• The others segment, which includes constipation, nausea, and pancreatic insufficiency, accounted for the largest share by application in 2016. This is a consequence of consistent efforts by government organizations for promoting awareness and enhancing management of these conditions

• The Crohn's disease segment is expected to grow at a lucrative rate over the coming years due to presence of extensive pipeline products in later stages of clinical trials

• Retail pharmacy accounted for the largest share by way of distribution channel in 2016 owing to high accessibility to retail stores and affordability. Online pharmacies are anticipated to witness lucrative CAGR as they usually offer price discounts on bulk purchases.

 Table of Contents

Chapter 1 Research Methodology & Scope
                  1.1 Region Wise Market Calculation
                      1.1.1 Region-wise market: Base estimates
                      1.1.2 Global market: CAGR calculation
                  1.2 Region-Based Segment Share Calculation
                  1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Gastrointestinal Therapeutics Market Variables, Trends & Scope
                  3.1 Market Segmentation & Scope
                  3.2 Market Driver Analysis
                      3.2.1 Increase in development of biologics
                      3.2.2 High prevalence of gastrointestinal diseases
                  3.3 Market Restraint Analysis
                      3.3.1 High number of patent expirations
                  3.4 Penetration & Growth Prospect Mapping
                  3.5 Gastrointestinal Therapeutics Market - SWOT Analysis, By Factor (Political & legal, economic, and technological)
                  3.6 Industry Analysis - Porter's
Chapter 4 Gastrointestinal Therapeutics Market: Type Estimates & Trend Analysis
                  4.1 Gastrointestinal Therapeutics Market: Type Movement Analysis
                  4.2 Branded
                      4.2.1 Branded market estimates and forecasts, 2014 - 2025 (USD Million)
                      4.2.2 Aminosalicylates
                          4.2.2.1 Aminosalicylates market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.2 Antacids
                              4.2.2.2.1 Antacids market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.3 Enzyme replacement therapies
                              4.2.2.3.1 Enzyme replacement therapies market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.4 Proton Pump Inhibitors
                              4.2.2.4.1 Proton pump inhibitors market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.5 Laxatives
                              4.2.2.5.1 Laxatives market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.6 Anti-emetics
                              4.2.2.6.1 Anti-emetics market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.7 H2 antagonists
                              4.2.2.7.1 H2 antagonists market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.8 Antidiarrheals
                              4.2.2.8.1 Antidiarrheals market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.9 Biologics
                              4.2.2.9.1 Biologics market estimates and forecasts, 2014 - 2025 (USD Million)
                          4.2.2.10 Others
                              4.2.2.10.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
                      4.2.3 Generics
                          4.2.3.1 Generics market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Gastrointestinal Therapeutics Market: Route of Administration Estimates & Trend Analysis
                  5.1 Gastrointestinal Therapeutics Market: Route of Administration Movement Analysis
                  5.2 Oral
                      5.2.1 Oral market estimates and forecasts, 2014 - 2025 (USD Million)
                  5.3 Intravenous
                      5.3.1 Intravenous market estimates and forecasts, 2014 - 2025 (USD Million)
                  5.4 Others
                      5.4.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Gastrointestinal Therapeutics Market: Application Estimates & Trend Analysis
                  6.1 Gastrointestinal Therapeutics Market: Application Movement Analysis
                  6.2 Ulcerative Colitis
                      6.2.1 Ulcerative Colitis market estimates and forecasts, 2014 - 2025 (USD Million)
                  6.3 Crohn's Disease
                      6.3.1 Crohn's disease market estimates and forecasts, 2014 - 2025 (USD Million)
                  6.4 Gastroesophageal Reflux (GERD)
                      6.4.1 GERD market estimates and forecasts, 2014 - 2025 (USD Million)
                  6.5 Others
                      6.5.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 7 Gastrointestinal Therapeutics Market: Distribution Channel Estimates & Trend Analysis
                  7.1 Gastrointestinal Therapeutics Market: Distribution Channel Movement Analysis
                  7.2 Hospital Pharmacies
                      7.2.1 Hospital pharmacies market estimates and forecasts, 2014 - 2025 (USD Million)
                  7.3 Retail Pharmacies
                      7.3.1 Retail pharmacies market estimates and forecasts, 2014 - 2025 (USD Million)
                  7.4 Online Pharmacies
                      7.4.1 Online pharmacies market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 8 Gastrointestinal Therapeutics Market: Regional Estimates & Trend Analysis, by Type, Route of Administration, Application, Distribution Channel
                  8.1 Gastrointestinal therapeutics market shares by region, 2016 & 2025
                  8.2 North America
                      8.2.1 North America gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.2.2 U.S.
                          8.2.2.1 U.S. gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025(USD Million)
                      8.2.3 Canada
                          8.2.3.1 Canada gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025(USD Million)
                  8.3 Europe
                      8.3.1 Europe gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.3.2 Germany
                          8.3.2.1 Germany gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.3.3 U.K.
                          8.3.3.1 U.K. gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025(USD Million)
                  8.4 Asia Pacific
                      8.4.1 Asia Pacific gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.4.2 Japan
                          8.4.2.1 Japan gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.4.3 China
                          8.4.3.1 China gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.4.4 India
                          8.4.4.1 India gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                  8.5 Latin America
                      8.5.1 Latin America gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.5.2 Brazil
                          8.5.2.1 Brazil gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.5.3 Mexico
                          8.5.3.1 Mexico gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                  8.6 MEA
                      8.6.1 MEA gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
                      8.6.2 South Africa
                          8.6.2.1 South Africa gastrointestinal therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 9 Competitive Landscape
                  9.1 Market participation categorization
                  9.2 List of Market Players
                  9.3 Company Profiles
                      9.3.1 Abbott Laboratories
                          9.3.1.1 Company overview
                          9.3.1.2 Financial performance
                          9.3.1.3 Product benchmarking
                      9.3.2 Allergan plc
                          9.3.2.1 Company overview
                          9.3.2.2 Financial performance
                          9.3.2.3 Product benchmarking
                          9.3.2.4 Strategic initiatives
                      9.3.3 AstraZeneca
                          9.3.3.1 Company overview
                          9.3.3.2 Financial performance
                          9.3.3.3 Product benchmarking
                      9.3.4 Bayer AG
                          9.3.4.1 Company overview
                          9.3.4.2 Financial performance
                          9.3.4.3 Product benchmarking
                      9.3.5 GlaxoSmithKline plc
                          9.3.5.1 Company overview
                          9.3.5.2 Financial performance
                          9.3.5.3 Product benchmarking
                      9.3.6 Janssen Pharmaceuticals
                          9.3.6.1 Company overview
                          9.3.6.2 Financial performance
                          9.3.6.3 Product benchmarking
                          9.3.6.4 Strategic initiatives
                      9.3.7 Takeda Pharmaceuticals
                          9.3.7.1 Company overview
                          9.3.7.2 Financial performance
                          9.3.7.3 Product benchmarking
                          9.3.7.4 Strategic initiatives
                      9.3.8 Valeant Pharmaceuticals
                          9.3.8.1 Company overview
                          9.3.8.2 Financial performance
                          9.3.8.3 Product benchmarking
                          9.3.8.4 Strategic initiatives
                      9.3.9 Pfizer
                          9.3.9.1 Company overview
                          9.3.9.2 Financial performance
                          9.3.9.3 Product benchmarking
                      9.3.10 AbbVie, Inc.
                          9.3.10.1 Company overview
                          9.3.10.2 Financial performance
                          9.3.10.3 Product benchmarking

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 3 North America branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 4 North America gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 5 North America gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 6 North America gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 7 U.S. gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 8 U.S. branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 9 U.S. gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 10 U.S. gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 11 U.S. gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 12 Canada gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 13 Canada branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 14 Canada gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 15 Canada gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 16 Canada gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 17 Europe gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 18 Europe branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 19 Europe gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 20 Europe gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 21 Europe gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 22 Germany gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 23 Germany branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 24 Germany gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 25 Germany gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 26 Germany gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 27 U.K. gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 28 U.K. branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 29 U.K. gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 30 U.K. gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 31 U.K. gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 32 Asia Pacific gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 33 Asia Pacific branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 34 Asia Pacific gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 35 Asia Pacific gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 36 Asia Pacific gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 37 Japan gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 38 Japan branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 39 Japan gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 40 Japan gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 41 Japan gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 42 China gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 43 China branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 44 China gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 45 China gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 46 China gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 47 India gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 48 India branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 49 India gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 50 India gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 51 India gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 52 Latin America gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 53 Latin America branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 54 Latin America gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 55 Latin America gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 56 Latin America gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 57 Brazil gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 58 Brazil branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 59 Brazil gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 60 Brazil gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 61 Brazil gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 62 Mexico gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 63 Mexico branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 64 Mexico gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 65 Mexico gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 66 Mexico gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 67 MEA gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 68 MEA branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 69 MEA gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 70 MEA gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 71 MEA gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 72 South Africa gastrointestinal therapeutics market, by type, 2014 - 2025 (USD Million)
TABLE 73 South Africa branded therapeutics market, by drug class, 2014 - 2025 (USD Million)
TABLE 74 South Africa gastrointestinal therapeutics market, by route of administration, 2014 - 2025 (USD Million)
TABLE 75 South Africa gastrointestinal therapeutics market, by application, 2014 - 2025 (USD Million)
TABLE 76 South Africa gastrointestinal therapeutics market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 77 List of Market Players

List of Figures

FIG. 1 Market summary (USD Million)
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (Political & legal, economic and technological)
FIG. 8 Porter's Five Forces Analysis
FIG. 9 Gastrointestinal therapeutics market, type outlook: Key takeaways
FIG. 10 Gastrointestinal therapeutics market: Type movement analysis
FIG. 11 Global branded market, 2014 - 2025 (USD Million)
FIG. 12 Global aminosalicylates market, 2014 - 2025 (USD Million)
FIG. 13 Global antacids market, 2014 - 2025 (USD Million)
FIG. 14 Global enzyme replacement therapies market, 2014 - 2025 (USD Million)
FIG. 15 Global proton pump inhibitors market, 2014 - 2025 (USD Million)
FIG. 16 Global laxatives market, 2014 - 2025 (USD Million)
FIG. 17 Global anti-emetics market, 2014 - 2025 (USD Million)
FIG. 18 Global H2 antagonists market, 2014 - 2025 (USD Million)
FIG. 19 Global antidiarrheals market, 2014 - 2025 (USD Million)
FIG. 20 Global biologics market, 2014 - 2025 (USD Million)
FIG. 21 Global others market, 2014 - 2025 (USD Million)
FIG. 22 Global generics market, 2014 - 2025 (USD Million)
FIG. 23 Gastrointestinal therapeutics market, route of administration outlook: Key takeaways
FIG. 24 Gastrointestinal therapeutics market: Route of administration movement analysis
FIG. 25 Global oral market, 2014 - 2025 (USD Million)
FIG. 26 Global intravenous market, 2014 - 2025 (USD Million)
FIG. 27 Global others market, 2014 - 2025 (USD Million)
FIG. 28 Gastrointestinal therapeutics market, application outlook: Key takeaways
FIG. 29 Gastrointestinal therapeutics market: Application movement analysis
FIG. 30 Global ulcerative colitis market, 2014 - 2025 (USD Million)
FIG. 31 Global crohn's disease market, 2014 - 2025 (USD Million)
FIG. 32 Global GERD market, 2014 - 2025 (USD Million)
FIG. 33 Global others market, 2014 - 2025 (USD Million)
FIG. 34 Gastrointestinal therapeutics market, distribution channel outlook: Key takeaways
FIG. 35 Gastrointestinal therapeutics market: Distribution channel movement analysis
FIG. 36 Global hospital pharmacies market, 2014 - 2025 (USD Million)
FIG. 37 Global retail pharmacies market, 2014 - 2025 (USD Million)
FIG. 38 Global online pharmacies market, 2014 - 2025 (USD Million)
FIG. 39 Regional market place: Key takeaways
FIG. 40 Regional outlook, 2016 & 2025
FIG. 41 North America gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 42 U.S. gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 43 Canada gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 44 Europe gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 45 Germany gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 46 U.K. gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 47 Asia Pacific gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 48 Japan gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 49 China gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 50 India gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 51 Latin America gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 52 Brazil gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 53 Mexico gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 54 MEA gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 55 South Africa gastrointestinal therapeutics market, 2014 - 2025 (USD Million)
FIG. 56 Participant categorization